MRD Assays Revolutionize Multiple Myeloma Drug Development: Accelerated Approvals & Personalized Therapies on the Horizon
Minimal residual disease (MRD) assessment has emerged as a game-changing biomarker in the multiple myeloma (MM) treatment landscape. Over the ...




